🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

From the first discovered case to FDA-approved gene therapies, we have over a century of milestones in research and treatment for sickle cell disease. Check out our interactive timeline: ow.ly/MolQ50TnbzT #Sicklecell #SickleCellAwarenessMonth #ConquerSCD

ASTCT and CIBMTR are excited to announce that registration is now open for #Tandem2025! Register now to join us Feb. 12-15, 2025, for four days of scientific updates, clinical trials, groundbreaking research and more. See you in Hawaii 🌺🏝️🐬 tandemmeetings.com

The science version of “what doesn’t kill me makes me stronger”: Scientists with ‘near misses’ early in their careers outperform those with ‘narrow wins’ in the longer run. nature.com/articles/s4146…

Check out our podcast on Outpatient #CARtcell Administration, I enjoyed the discussion with this expert team. Thank you ASTCT for organzing this effort and for tackling important issues in our field Zahra M, PharmD, MBA, BCOP, FHOPA Akshay Sharma MD J Holter Chakrabarty podcasts.apple.com/us/podcast/out…

🚨 due Friday! (Quick) application for ASTCT committees. Honored for Shernan Holtan MD and me to be new ASTCT Content Comm chairs (🙏 Akshay Sharma MD Andres Gomez ) Come join us so you can tweet all year for a good cause 😉 #BMTsm #TcellRx #MMsm #lymsm #leusm surveymonkey.com/r/BFLL5B9

For all Cell Therapy experts in India & across the APAC region—Academia & Industry! Don’t miss this unique opportunity to present your research at Our 4th Annual APAC Cell Therapy Conference, SACT 2025 !! CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC ACTREC-TMC Gaurav Narula MD Join 25+ global pioneers from

The bacteria in your gut depend on where you are in the social network. And the microbes within us treat our social networks as the extended environment in which they thrive. They can spread from person to person. New #HNL work out today in nature. 1/

If you're a hematologist thinking of making a change, we have a session for you next Sunday at #ASH24: "Symposium for Mid-Career Hematologists." Discussing leadership roles, job changes; academia, industry & beyond. Chair Shruti Chaturvedi, speakers include Ruben A. Mesa, MD Nina Shah & me.

🧵Twitter Thread:🧵 EBMT 2025 Abstract Submission & Opportunities! 1/ 🚨 Reminder for Physicians, Data Managers, Statisticians, Psychologists, Pharmacists & Patient Advocates! You have 1 week left to submit your abstracts for #EBMT25. 🗓 Deadline: This Sunday! Submit here 👉

🚨PublicationAlert🚨 How I Treat Sickle Cell Disease with Gene Therapy, published online (authors.elsevier.com/a/1kKhU1UYwnGSK ) and in print in Blood Journal Many thanks to Alexis Thompson Julie Kanter Lakshmanan Krishnamurti Shalini Shenoy MD Brandon Triplett and A Abraham for their inputs 🙏

How I treat sickle cell disease with gene therapy ow.ly/nxY050Ux3fQ #HowITreat #genetherapy #redcellsironanderythropoiesis #sicklecelldisease #transplantation

Explore the latest ASTCT evidence-based guidelines for #alloHCT in severe aplastic anemia (SAA). Key updates include graft source preferences, expanded donor options and refined GVHD prophylaxis. Read more: astctjournal.org/article/S2666-…

Gene therapy offers new hope for sickle cell anemia, surpassing traditional treatments like alloHCT. Can we overcome the cost & delivery hurdles in low- & middle-income nations? Read Akshay Sharma MD's brilliant article to see how he treats sickle cell disease with gene therapy!

🧵1/ Last year, a thoughtful reply to our JAMA article sent me down a rabbit hole on CVD prevention. Should statins be prescribed less or more often? Available OTC? Added to the water supply?? Let’s talk trials, thresholds, and tradeoffs!

The Pediatric Rare Disease Priority Review Voucher Program, incentivising pediatric rare diseases including #ChildhoodCancer has expired . Ask Congress to reauthorize the program - Give Kids a Chance Act of 2025 (H.R. 1262) - Kids v Cancer congressweb.com/KVC/12/

Nonclinical evaluation of HBG1/2 and BCL11A as genome-editing targets for the treatment of β-hemoglobinopathies ow.ly/Saif50V6oMO #genetherapy

Sickle Cell Disease is a complex, evolving condition. Join us for a complimentary virtual symposium Memorial Sloan Kettering Cancer Center featuring expert-led sessions, a keynote by Dr. Julie Kanter on optimizing gene therapy, and compelling stories from those living with SCD during our warrior

2012 a friend said- “Science Fiction” 2015 we dared to dream Sharing 🇮🇳 1st novel #CARTCellRx Ph 1/1b trial We report 92% ORR 3 dose levels nature Blood Cancer Journal Rahul Purwar ImmunoACT CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC Nirali Shah Tata Memorial Hospital Swaminathan K Alka Dwivedi rdcu.be/ei7xh

Will gene therapy transform the future of #SickleCellDisease care?🩸🧬 We've just published a podcast episode in which Akshay Sharma MD provides valuable insights into this therapeutic approach. Don’t miss it! 🎧🎙️ Listen here: 👉 ow.ly/rGMG50VXIOL #Hematology

This study has identified the impact of HLA alloimmunization in autologous gene-modified hematopoietic cell transplantation for transfusion-dependent thalassemia. ow.ly/WjQA50W1eIT #genetherapy